Company profile
UK company 02341404, incorporated on 31 January 1989.
Artificial Intelligence and Machine Learning enabled Information Systems and Solutions | AES Group
We strive to be true partners with our customers by helping them successfully achieve their objectives, on projects both large and small, through innovation and creative solutions.
Company number 02341404
Updated 07 Jul 2026 09:49
Reference milestones and recent Companies House filing stream events.
Next accounts due date
CS01 | Transaction MzUzNzM5NDQzMGFkaXF6a2N4
Published 09 Aug 2026 07:32
Next confirmation statement due date
PSC04 | Transaction MzUzNzM5MzQyOGFkaXF6a2N4
Published 06 Aug 2026 15:23
Last confirmation statement made up date
Last accounts made up date
Company registered at Companies House
1 Oct 2022 to 31 Mar 2025
Faecal immunochemical testing (FIT) measures faecal haemoglobin concentration (f-Hb). FIT can be used to manage patients presenting in primary care with unexplained lower gastrointestinal (GI) symptoms that may be indicative of bowel cancer in primary care prior to (or alongside) an urgent referral, or for triaging in secondary care to guide the managemen...
1 Nov 2021 to 31 Jan 2024
**NEED:** The UK's Bowel Cancer Screening Programme (BCSP) has been revolutionised by improved diagnostic methodology, the Faecal Immunochemical Test (FIT). FIT is easy to undertake (only one sample required), and so screening participation has increased from 59.4% to 67.5% of eligible adults aged \>50 years. Any participant exceeding a pre-determined FIT...
1 Nov 2018 to 31 Oct 2019
"Bowel cancer screening services invite asymptomatic persons aged \>60 years to conduct guaiac-based Faecal Occult Blood testing (gFOBt) every two years. From Autumn 2018, NHS England's Bowel Cancer Screening Programme (BCSP; commissioned by Public Health England; PHE) will roll-out Faecal Immunochemical Test (FIT) to replace gFOBt. FIT is simpler, more s...
